A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data
Background: Comorbidity measures are necessary to describe patient populations and
adjust for confounding. In direct comparisons, studies have found the Elixhauser comorbidity …
adjust for confounding. In direct comparisons, studies have found the Elixhauser comorbidity …
The incidence and severity of adverse events affecting patients after discharge from the hospital
AJ Forster, HJ Murff, JF Peterson… - Annals of internal …, 2003 - acpjournals.org
Background: Studies of hospitalized patients identify safety as a significant problem, but few
data are available regarding injuries occurring after discharge. Patients may be vulnerable …
data are available regarding injuries occurring after discharge. Patients may be vulnerable …
Adverse events among medical patients after discharge from hospital
AJ Forster, HD Clark, A Menard, N Dupuis, R Chernish… - Cmaj, 2004 - Can Med Assoc
Background: Adverse events (AEs) are adverse outcomes caused by medical care. Several
studies have indicated that a substantial number of patients experience AEs before or during …
studies have indicated that a substantial number of patients experience AEs before or during …
[HTML][HTML] The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI …
…, GG Grütz, AD Agulnick, H Westphal, A Forster… - The EMBO …, 1997 - embopress.org
The LIM‐only protein Lmo2, activated by chromosomal translocations in T‐cell leukaemias,
is normally expressed in haematopoiesis. It interacts with TAL1 and GATA‐1 proteins, but the …
is normally expressed in haematopoiesis. It interacts with TAL1 and GATA‐1 proteins, but the …
Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community
Background: Readmissions to hospital are common, costly and often preventable. An easy-to-use
index to quantify the risk of readmission or death after discharge from hospital would …
index to quantify the risk of readmission or death after discharge from hospital would …
The association between continuity of care and outcomes: a systematic and critical review
…, N Oake, A Jennings, AJ Forster - Journal of evaluation …, 2010 - Wiley Online Library
Background Numerous studies have tried to determine the association between continuity
and outcomes. Studies doing so must actually measure continuity. If continuity and outcomes …
and outcomes. Studies doing so must actually measure continuity. If continuity and outcomes …
Proportion of hospital readmissions deemed avoidable: a systematic review
…, C Bennett, A Jennings, PC Austin, AJ Forster - Cmaj, 2011 - Can Med Assoc
Background Readmissions to hospital are increasingly being used as an indicator of quality
of care. However, this approach is valid only when we know what proportion of …
of care. However, this approach is valid only when we know what proportion of …
[HTML][HTML] An Mll–AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes
Homologous recombination in embryonal stem cells has been used to produce a fusion
oncogene, thereby mimicking chromosomal translocations that frequently result in formation of …
oncogene, thereby mimicking chromosomal translocations that frequently result in formation of …
[PDF][PDF] Technetium-99m d, l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion
…, RA Holmes, WA Volkert, AM Forster… - Journal of Nuclear …, 1987 - Soc Nuclear Med
Following investigation of a large number of new ligands based upon propylene amine
oxime (PnAO) the d, l-diastereoisomer of hexamethyl propyleneamine oxime (HM-PAO) was …
oxime (PnAO) the d, l-diastereoisomer of hexamethyl propyleneamine oxime (HM-PAO) was …
Adverse drug events occurring following hospital discharge
AJ Forster, HJ Murff, JF Peterson, TK Gandhi… - Journal of general …, 2005 - Springer
OBJECTIVE: To describe the incidence of adverse drug events (ADEs), preventable ADEs,
and ameliorable ADEs occurring after hospital discharge and their associated risk factors. …
and ameliorable ADEs occurring after hospital discharge and their associated risk factors. …